X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with Compact Disc - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs COMPACT DISC - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

COMPACT DISC 
   Change

Compact Disc Indai (CDI) is India's leading integrated media and entertainment company and South Asia's largest animation company with prime focus on animation outsourcing and production. Incorporated in 1992, its product range covers all the segment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES COMPACT DISC INDOCO REMEDIES/
COMPACT DISC
 
P/E (TTM) x 23.2 -7.8 - View Chart
P/BV x 2.8 0.0 14,478.8% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 INDOCO REMEDIES   COMPACT DISC
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
COMPACT DISC
Mar-13
INDOCO REMEDIES/
COMPACT DISC
5-Yr Chart
Click to enlarge
High Rs36031 1,162.6%   
Low Rs2499 2,896.5%   
Sales per share (Unadj.) Rs119.00-  
Earnings per share (Unadj.) Rs8.4-0.3 -2,882.0%  
Cash flow per share (Unadj.) Rs15.2-0.2 -6,264.2%  
Dividends per share (Unadj.) Rs1.600-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs70.789.7 78.8%  
Shares outstanding (eoy) m92.1512.75 722.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.6NM-  
Avg P/E ratio x36.4-68.2 -53.4%  
P/CF ratio (eoy) x20.0-81.4 -24.6%  
Price / Book Value ratio x4.30.2 1,953.7%  
Dividend payout %19.10-   
Avg Mkt Cap Rs m28,083252 11,124.1%   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,1671 361,116.7%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,9680-  
Other income Rs m400-   
Total revenues Rs m11,0070-   
Gross profit Rs m1,565-3 -52,153.3%  
Depreciation Rs m6331 105,466.7%   
Interest Rs m620-   
Profit before tax Rs m909-4 -25,261.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1390 138,700.0%   
Profit after tax Rs m771-4 -20,829.7%  
Gross profit margin %14.3NM- 
Effective tax rate %15.3-2.8 -549.1%   
Net profit margin %7.0NM- 
BALANCE SHEET DATA
Current assets Rs m5,725627 913.6%   
Current liabilities Rs m5,454157 3,476.2%   
Net working cap to sales %2.5NM- 
Current ratio x1.04.0 26.3%  
Inventory Days Days62NM- 
Debtors Days Days72NM- 
Net fixed assets Rs m5,30725 21,144.9%   
Share capital Rs m184127 144.9%   
"Free" reserves Rs m6,3311,017 622.5%   
Net worth Rs m6,5161,144 569.4%   
Long term debt Rs m1,323178 745.4%   
Total assets Rs m11,9701,480 809.0%  
Interest coverage x15.6NM-  
Debt to equity ratio x0.20.2 130.9%  
Sales to assets ratio x0.90-   
Return on assets %7.0-0.3 -2,782.3%  
Return on equity %11.8-0.3 -3,658.3%  
Return on capital %12.4-0.3 -4,550.6%  
Exports to sales %0NM-  
Imports to sales %0NM-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,5070-   
Fx outflow Rs m1,1410-   
Net fx Rs m3,3660-   
CASH FLOW
From Operations Rs m8860 295,466.7%  
From Investments Rs m-1,706-1 284,250.0%  
From Financial Activity Rs m1,316NA-  
Net Cashflow Rs m4970 -165,533.3%  

Share Holding

Indian Promoters % 59.2 22.6 261.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 77.4 28.9%  
Shareholders   12,805 28,898 44.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   CREST VENTURES  NESCO LIMITED  THOMAS COOK INDIA  RELIGARE ENT.  MOTILAL OSWAL  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - EDELWEISS FINANCIAL COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS